Compare Nutrien Ltd (NTR) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutrien Ltd vs Novartis AG — how do they compare? Nutrien Ltd trades at $67.3 (market cap $32.05B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 9.2× Nutrien Ltd's market cap, and Nutrien Ltd pays the higher dividend (3.27%). Which is the better fit depends on your goals.
| NTR | NVS | |
|---|---|---|
Market Cap | $32.05B | $295.37B |
Sector | Basic Materials | Health |
52-Week High | $83.94 | $168.62 |
52-Week Low | $53.64 | $119.31 |
Enterprise Value | $43.86B | $336.69B |
Dividend Yield | 3.27% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
